Piramal Enterprises Limited (PEL), a publicly listed company in India, has diversified business interests in Financial Services and Pharmaceuticals. PELs consolidated revenues were ~US$1.7 billion in FY2020, with ~34% of revenues generated from outside India.
Anticipating the potential of financial services in India, PEL built a platform with innovative financial solutions that cater to the needs of varied industry verticals.
When the Indian pharmaceutical industry was focused on international generics, PEL saw an opportunity to expand its pharma business and invested in the domestic formulation business.
PELs corporate ethos, a reflection of its core values Knowledge, Action, Care and Impact, has enabled the company to develop and consolidate a coveted international business network of strong partnerships with global market leaders, committed to creating long-term value to all stakeholders.